Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.78
+0.07 (1.23%)
At close: Apr 28, 2026, 4:00 PM EDT
5.62
-0.16 (-2.71%)
After-hours: Apr 28, 2026, 5:59 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $18.54 million as of April 28, 2026. Its market cap has decreased by -17.56% in one year.
Market Cap
18.54M
Enterprise Value
-3.98M
1-Year Change
-17.56%
Ranking
Category
Stock Price
$5.78
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $18.54M, a decrease of -98.06%. That is a compound annual growth rate of -47.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 21.24M |
| Allarity Therapeutics | 21.20M |
| Quantum BioPharma | 21.09M |
| Cocrystal Pharma | 19.71M |
| Psyence Biomedical | 18.14M |
| Lipocine | 17.67M |
| Theriva Biologics | 17.49M |
| Citius Pharmaceuticals | 17.23M |